Wheels Up Q2 2025 earnings show revenue miss at $189.64M vs. $484.68M estimate but EPS beats at -$0.10 vs. -$1.95. Stock rises pre-market on cost control optimism.
Amidst widespread speculation, the return of President Trump as commander-in-chief could threaten earnings growth in the defense industry in 2025. That said, the main reason for caution lies in the fundamentals themselves.
10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeutics, Joby Aviation, Crinetics Pharmaceuticals, Dyne Therapeutics, Summit Therapeutics, Plug Power and XPeng Inc.
